The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS
Autor: | Teresa Bernal, Lurdes Zamora, Rosa Collado, María-José Jiménez, Fernando Ramos, María-Luz Amigo, Carme Pedro, David Valcárcel, Maria-Teresa Cedena, Guillermo Sanz, M.T. Ardanaz, Marina Díaz-Beyá, Javier Grau, Laura Palomo, Esperanza Such, Olga García, Blanca Xicoy, Ana Triguero, Montserrat Arnan |
---|---|
Rok vydání: | 2018 |
Předmět: |
Male
Cancer Research medicine.medical_specialty Chronic myelomonocytic leukemia Outcome (game theory) World health Diagnosis Differential 03 medical and health sciences 0302 clinical medicine Internal medicine medicine Humans business.industry Large series Leukemia Myelomonocytic Chronic Hematology Prognosis medicine.disease Oncology Myelodysplastic Syndromes 030220 oncology & carcinogenesis Practice Guidelines as Topic Female Who classification business 030215 immunology |
Zdroj: | Leukemia Research. 70:34-36 |
ISSN: | 0145-2126 |
Databáze: | OpenAIRE |
Externí odkaz: |